180 Wealth Advisors, LLC Infinity Pharmaceuticals, Inc. Transaction History

180 Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 17, 2020	SELL	$0.88 - $1.29 $22,000 - $32,250	-25,000 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$1.18 - $1.91 $5,900 - $9,550	-5,000 Reduced 16.67%	25,000 $43,000
Q2 2018 Aug 08, 2018	BUY	$1.72 - $2.26 $17,200 - $22,599	10,000 Added 50.0%	30,000 $57,000
Q1 2018 Jun 01, 2018	BUY	$1.8 - $2.74 $36,000 - $54,800	20,000 New	20,000 $42,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of 180 Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on 180 Wealth Advisors, LLC with notifications on news.